Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo
Karuna Therapeutics Inc. logo

Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
BMY· Bristol-Myers Squibb CompanyKRTX· Karuna Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company), KRTX (Karuna Therapeutics Inc.) and more on Quantisnow.

Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics | Quantisnow